interleukin 4, data not shown) would be unable to use these networks, which would also account for the low levels of TP observed in high-grade tumours. Although no significant reduction in relapse-free survival or overall survival was observed in all patients or the node- negative subgroup, there was a significantly higher relapse- free survival and borderline significance for overall survival in node-positive patients with TP-positive tumours.
← all excerpts
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
1
—
—